Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Valvular Heart Disease

  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 68 articles:
HTML format

Single Articles

    September 2021
  1. DESAI MY, Wolski K, Owens A, Naidu SS, et al
    Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy.
    Am Heart J. 2021;239:80-89.
    PubMed     Abstract available

    April 2021
  2. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.

    March 2021
  3. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available

  4. LOWENSTERN A, Sheridan P, Wang TY, Boero I, et al
    Sex Disparities in Patients with Symptomatic Severe Aortic Stenosis.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00074.
    PubMed     Abstract available

  5. WAKSMAN R, Torguson R, Medranda GA, Shea C, et al
    Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.
    Am Heart J. 2021 Mar 10. pii: S0002-8703(21)00071.
    PubMed     Abstract available

    January 2021
  6. ADACHI Y, Yamamoto M, Shimura T, Yamaguchi R, et al
    Late kidney injury after transcatheter aortic valve replacement.
    Am Heart J. 2021 Jan 14. pii: S0002-8703(21)00011.
    PubMed     Abstract available

  7. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

    December 2020
  8. MENTIAS A, Sarrazin MV, Desai M, Kapadia S, et al
    Expansion of Transcatheter Aortic Valve Replacement in the United States: Expansion of TAVR in US.
    Am Heart J. 2020 Dec 31. pii: S0002-8703(20)30427.
    PubMed     Abstract available

    November 2020
  9. KAWASHIMA H, Soliman O, Wang R, Ono M, et al
    Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.
    Am Heart J. 2020 Nov 5. pii: S0002-8703(20)30368.
    PubMed     Abstract available

  10. LACHTRUPP CL, Valente AM, Gurvitz M, Landzberg MJ, et al
    Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease.
    Am Heart J. 2020;229:92-99.
    PubMed     Abstract available

    October 2020
  11. NATHAN AS, Yang L, Geng Z, Dayoub EJ, et al
    Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.
    Am Heart J. 2020;232:1-9.
    PubMed     Abstract available

  12. GUIMARAES HP, de Barros E Silva PGM, Liporace IL, Sampaio RO, et al
    A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
    Am Heart J. 2020 Oct 9. pii: S0002-8703(20)30277.
    PubMed     Abstract available

    August 2020
  13. AZEVEDO O, Marques N, Reis L, Cruz I, et al
    Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
    Am Heart J. 2020;226:114-126.
    PubMed     Abstract available

    July 2020
  14. BHARDWAJ B, Cohen DJ, Vemulapalli S, Kosinski AS, et al
    Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.
    Am Heart J. 2020;228:57-64.
    PubMed     Abstract available

  15. HERKERT JC, Verhagen JMA, Yotti R, Haghighi A, et al
    Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
    Am Heart J. 2020;225:108-119.
    PubMed     Abstract available

    June 2020
  16. ELTCHANINOFF H, Bonaros N, Prendergast B, Nietlispach F, et al
    Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve interventio
    Am Heart J. 2020;228:27-35.
    PubMed     Abstract available

  17. HOLMES DR JR, Mack MJ, Alkhouli M, Vemulapalli S, et al
    Racial disparities and democratization of health care: A focus on TAVR in the United States.
    Am Heart J. 2020;224:166-170.

    April 2020
  18. LUDWIG S, Gossling A, Waldschmidt L, Linder M, et al
    TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification.
    Am Heart J. 2020;225:138-148.
    PubMed     Abstract available

  19. DAMLUJI AA, Rodriguez G, Noel T, Davis L, et al
    Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
    Am Heart J. 2020;224:171-181.
    PubMed     Abstract available

    March 2020
    Consequences of impressive myectomy results in a Center of Excellence: The paradox of evidence-based medicine era.
    Am Heart J. 2020;221:157-158.

  21. GESKE JB, Driver CN, Yogeswaran V, Ommen SR, et al
    Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy.
    Am Heart J. 2020;221:159-164.
    PubMed     Abstract available

    February 2020
  22. PINEDA AM, Rymer J, Wang A, Banks AZ, et al
    Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.
    Am Heart J. 2020;224:105-112.
    PubMed     Abstract available

  23. ROZENBAUM Z, Finkelstein A, Zhitomirsky S, Topilsky Y, et al
    Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Am Heart J. 2020;220:184-191.
    PubMed     Abstract available

    January 2020
  24. KALBACHER D, Tigges E, Boekstegers P, Puls M, et al
    Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.
    Am Heart J. 2020;222:73-82.
    PubMed     Abstract available

  25. LU DY, Ventoulis I, Liu H, Kudchadkar SM, et al
    Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
    Am Heart J. 2020;219:58-69.
    PubMed     Abstract available

    December 2019
  26. MEGALY M, Gossl M, Sorajja P, Anzia LE, et al
    Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement.
    Am Heart J. 2019;218:128-132.
    PubMed     Abstract available

    October 2019
  27. VENN RA, Ning M, Vlahakes GJ, Wasfy JH, et al
    Surgical timing in infective endocarditis complicated by intracranial hemorrhage.
    Am Heart J. 2019;216:102-112.
    PubMed     Abstract available

    August 2019
  28. PAPOUTSIDAKIS N, Heitner S, Ingles J, Semsarian C, et al
    Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude.
    Am Heart J. 2019;214:28-35.
    PubMed     Abstract available

    July 2019
  29. ADAMO M, Grasso C, Capodanno D, Rubbio AP, et al
    Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry.
    Am Heart J. 2019;217:32-41.
    PubMed     Abstract available

    April 2019
  30. LARIOS G, Yim D, Dragulescu A, Mertens L, et al
    Right ventricular function in patients with pulmonary regurgitation with versus without tetralogy of Fallot.
    Am Heart J. 2019;213:8-17.
    PubMed     Abstract available

    March 2019
  31. BING R, Everett RJ, Tuck C, Semple S, et al
    Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial.
    Am Heart J. 2019;212:91-100.
    PubMed     Abstract available

  32. PRIROMPRINTR B, Silka MJ, Rhodes J, Batra AS, et al
    A prospective 5-year study of exercise performance following Melody valve implant.
    Am Heart J. 2019;209:47-53.
    PubMed     Abstract available

    August 2018
  33. VAN MIEGHEM NM, Unverdorben M, Valgimigli M, Mehran R, et al
    EdoxabaN Versus standard of care and theIr effectS on clinical outcomes in pAtients havinG undergonE Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
    Am Heart J. 2018;205:63-69.
    PubMed     Abstract available

  34. MACK MJ, Abraham WT, Lindenfeld J, Bolling SF, et al
    Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Am Heart J. 2018;205:1-11.
    PubMed     Abstract available

    July 2018
  35. FEYZ L, El Faquir N, Lemmert ME, Misier KR, et al
    Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.
    Am Heart J. 2018;204:83-91.
    PubMed     Abstract available

    June 2018
  36. COLLET JP, Berti S, Cequier A, Van Belle E, et al
    Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
    Am Heart J. 2018;200:44-50.
    PubMed     Abstract available

  37. STEINVIL A, Buchanan KD, Kiramijyan S, Bond E, et al
    Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.
    Am Heart J. 2018;200:11-16.
    PubMed     Abstract available

    May 2018
  38. SAMAD Z, Shaw LK, Phelan M, Glower DD, et al
    Long-term outcomes of mitral regurgitation by type and severity.
    Am Heart J. 2018;203:39-48.
    PubMed     Abstract available

  39. SHIBATA K, Yamamoto M, Kano S, Koyama Y, et al
    Importance of Geriatric Nutritional Risk Index assessment in patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2018;202:68-75.
    PubMed     Abstract available

  40. CZARNECKI A, Qiu F, Koh M, Alter DA, et al
    Trends in the incidence and outcomes of patients with aortic stenosis hospitalization.
    Am Heart J. 2018;199:144-149.
    PubMed     Abstract available

    April 2018
  41. EL-HARASIS MA, Connolly HM, Miranda WR, Qureshi MY, et al
    Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a "low-risk" group.
    Am Heart J. 2018;201:136-140.
    PubMed     Abstract available

  42. GALPER BZ, Beery DE, Leighton G, Englander LL, et al
    Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data.
    Am Heart J. 2018;198:64-74.
    PubMed     Abstract available

    March 2018
  43. FANNING JP, Wesley AJ, Walters DL, Wong AA, et al
    Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.
    Am Heart J. 2018;197:113-123.
    PubMed     Abstract available

    February 2018
  44. BUCHANAN KD, Rogers T, Alraies MC, Steinvil A, et al
    Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United States.
    Am Heart J. 2018;196:74-81.
    PubMed     Abstract available

  45. EGBE A, Khan AR, Miranda WR, Ammash NM, et al
    Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
    Am Heart J. 2018;196:144-152.
    PubMed     Abstract available

    January 2018
  46. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
    Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Am Heart J. 2018;195:1-13.
    PubMed     Abstract available

  47. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.
    Am Heart J. 2018;195:153-154.

    December 2017
  48. BARON SJ, Arnold SV, Reynolds MR, Wang K, et al
    Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Am Heart J. 2017;194:39-48.
    PubMed     Abstract available

  49. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Abstract available

    October 2017
  50. MOJOLI M, Gersh BJ, Barioli A, Masiero G, et al
    Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Am Heart J. 2017;192:64-75.
    PubMed     Abstract available

  51. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Am Heart J. 2017;192:57-63.
    PubMed     Abstract available

    July 2017
  52. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez AF, et al
    Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Am Heart J. 2017;189:146-157.
    PubMed     Abstract available

  53. ROGERS T, Torguson R, Bastian R, Corso P, et al
    Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.
    Am Heart J. 2017;189:103-109.
    PubMed     Abstract available

    June 2017
  54. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Abstract available

    May 2017
  55. ARENDT CJ, Hong JH, Daly RC, Scott C, et al
    Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.
    Am Heart J. 2017;187:70-77.
    PubMed     Abstract available

  56. HO CY, McMurray JJV, Cirino AL, Colan SD, et al
    The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
    Am Heart J. 2017;187:145-155.
    PubMed     Abstract available

    March 2017
  57. KLECZYNSKI P, Dziewierz A, Bagienski M, Rzeszutko L, et al
    Impact of frailty on mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;185:52-58.
    PubMed     Abstract available

    February 2017
  58. MARTIN GP, Sperrin M, Ludman PF, de Belder MA, et al
    Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;184:97-105.
    PubMed     Abstract available

  59. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Abstract available

  60. SORENSEN LL, Liang HY, Pinheiro A, Hilser A, et al
    Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Am Heart J. 2017;184:47-54.
    PubMed     Abstract available

    December 2016
  61. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Abstract available

  62. PRESSLER A, Christle JW, Lechner B, Grabs V, et al
    Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.
    Am Heart J. 2016;182:44-53.
    PubMed     Abstract available

  63. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Abstract available

  64. CHAUHAN D, Haik N, Merlo A, Haik BJ, et al
    Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:146-154.
    PubMed     Abstract available

    October 2016
  65. WINDECKER S, Tijssen J, Giustino G, Guimaraes AH, et al
    Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Am Heart J. 2016;184:81-87.
    PubMed     Abstract available

  66. VOLLENBROICH R, Stortecky S, Praz F, Lanz J, et al
    The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2016;184:71-80.
    PubMed     Abstract available

    September 2016
  67. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Abstract available

    August 2016
  68. MARTINS RP, Galand V, Colette E, Behar N, et al
    Defining nonvalvular atrial fibrillation: A quest for clarification.
    Am Heart J. 2016;178:161-7.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.